Ledger.Open graph →
SEC Form D · filed September 13, 2024

Candid Therapeutics, Inc

Offering
$206.2M
Sold
$206.2M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Jeffrey Tong, Ph.D · San Diego, CADirectorArvind Kush · San Diego, CAExecTimothy Lu, M.D · San Diego, CAExecKenneth Song, M.D · San Diego, CAExec · DirectorAaron Royston, M.D · San Diego, CADirectorBernie Huyghe, Ph.D · San Diego, CAExecMichael Rome, M.D · San Diego, CADirectorJeffrey Tong, Ph.D · San Diego, CADirectorArvind Kush · San Diego, CAExecTimothy Lu, M.D · San Diego, CAExecKenneth Song, M.D · San Diego, CAExec · DirectorAaron Royston, M.D · San Diego, CADirectorBernie Huyghe, Ph.D · San Diego, CAExecMichael Rome, M.D · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗